Last updated: June 17, 2021
Sponsor: New York University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Respiratory Syncytial Virus (Rsv) Infection
Treatment
N/AClinical Study ID
NCT04929691
CDC Foundation Award 1085.1
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Adult patients admitted to a study site with respiratory distress and suspected orconfirmed COVID-19 infection
Exclusion
Exclusion Criteria:
- Patients who do not meet eligibility criteria
Study Design
Total Participants: 370
Study Start date:
November 13, 2020
Estimated Completion Date:
December 31, 2021
Study Description
Connect with a study center
Nigerian Institute of Medical Research
Yaba, Lagos
NigeriaActive - Recruiting
Federal Medical Center, Abeokuta
Abeokuta,
NigeriaActive - Recruiting
Alex Ekwueme Federal University Teaching Hospital
Enugu,
NigeriaActive - Recruiting
Enugu State University Teaching Hospital
Enugu,
NigeriaActive - Recruiting
University College Hospital
Ibadan,
NigeriaActive - Recruiting
Aminu Kano Teaching Hospital
Kano,
NigeriaActive - Recruiting
Federal Medical Center, Ebute Metta
Lagos,
NigeriaActive - Recruiting
Lagos University Teaching Hospital
Lagos,
NigeriaActive - Recruiting
Delta State University Teaching Hospital
Oghara,
NigeriaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.